Camp4 Therapeutics Corp (CAMP)
CIK 1736730 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Camp4 Therapeutics Corp.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 2, 2026 | 4 | 0001628280-26-060234 |
| Aug 31, 2026 | SCHEDULE 13D/A | 0001753037-26-000007 |
| Aug 31, 2026 | 4 | 0001598549-26-000011 |
| Aug 26, 2026 | 4 | 0001598549-26-000009 |
| Aug 21, 2026 | 4 | 0001598549-26-000007 |
| Aug 19, 2026 | 4 | 0001628280-26-058107 |
| Aug 19, 2026 | 144 | 0001974494-26-000263 |
| Aug 19, 2026 | SCHEDULE 13D/A | 0001193125-26-357272 |
| Aug 14, 2026 | SCHEDULE 13G/A | 0001172661-26-003419 |
| Aug 13, 2026 | 10-Q | 0001628280-26-056760 |
| Aug 13, 2026 | 8-K | 0001628280-26-056758 |
| Aug 12, 2026 | 424B3 | 0001628280-26-056325 |
| Aug 12, 2026 | EFFECT | 9999999995-26-002650 |
| Aug 10, 2026 | SCHEDULE 13G | 0001493152-26-036926 |
| Aug 6, 2026 | S-3 | 0001628280-26-054389 |
| Aug 5, 2026 | 4 | 0001231919-26-000829 |
| Aug 5, 2026 | 4 | 0001628280-26-053511 |
| Aug 5, 2026 | SCHEDULE 13D/A | 0001753037-26-000003 |
| Aug 5, 2026 | 4 | 0001628280-26-053512 |
| Aug 5, 2026 | 4 | 0001598549-26-000002 |
| Aug 5, 2026 | 4 | 0001628280-26-053513 |
| Aug 5, 2026 | 4 | 0001628280-26-053505 |
| Aug 4, 2026 | 8-K | 0001628280-26-052150 |
| Jul 27, 2026 | 8-K | 0001628280-26-049661 |
| Jun 12, 2026 | 4 | 0001628280-26-042863 |